Form D · Biotechnology

AMORCYTE INC

Allendale, NJ · CIK 0001349940

Offering snapshot reported Jul 21, 2011 · SEC filing

Reported sold
$500K
Offering amount: $1.2M
Investors reported
1
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Jul 13, 2011
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 21, 2011Initial$500,000No comparison1SEC filing
Nov 24, 2010Initial$525,000No comparison9SEC filing
Jan 2, 2009PaperNot reportedNo comparisonNot reportedSEC filing
May 9, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Jun 13, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Jan 10, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Debt
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-163259

Source: Form D, filed Jul 21, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Darren Blanton Director
George Goldberger Executive
Hans Mueller Director
Desmond O'connell Director
Desmond O Connell Director
Andrew Pecora Executive
Paul Schmit Director, Executive
Paul J. Schmitt Director, Executive
Michael Starcher Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
4 Pearl Court, Suite C
Allendale, NJ, 07401